Staff Profile

Research

PDRA in the structural biology group of the Cancer Research Horizons Newcastle Drug Discovery Unit. My areas of expertise are drug discovery, computational chemistry and biophysics.

Google Scholar: Natalie J. Tatum 

LinkedIn: Natalie J. Tatum

• Articles

  • Rowland RJ, Korolchuk S, Salamina M, Tatum NJ, Ault JR, Hart S, Turkenburg JP, Blaza JN, Noble MEM, Endicott JA. Cryo-EM structure of the CDK2-cyclin A-CDC25A complex. Nature Communications 2024, 15(1), 6807.
  • Alblihy A, Ali R, Algethami M, Shoqafi A, Toss MS, Brownlie J, Tatum NJ, Hickson I, Moran PO, Grabowska A, Jeyapalan JN, Mongan NP, Rakha EA, Madhusudan S. Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers. npj Precision Oncology 2022, 6, 51.
  • Bieniek MK, Cree B, Pirie R, Horton JT, Tatum NJ, Cole DJ. An Open-Source Molecular Builder and Free Energy Preparation Workflow. Communications Chemistry 2022, 5, 136.
  • Mesquita KA, Ali R, Doherty R, Toss MS, Miligy I, Alblihy A, Dorjsuren D, Simeonov A, Jadhav A, Wilson DM, Hickson I, Tatum NJ, Rakha EA, Madhusudan S. FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers. Cancers 2021, 13(8), 1866.
  • Salamina M, Montefiore BC, Liu M, Wood DJ, Heath R, Ault JR, Wang L-Z, Korolchuk S, Basle A, Pastok MW, Reeks J, Tatum NJ, Sobott F, Arold ST, Pagano M, Noble MEM, Endicott JA. Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation. Journal of Molecular Biology 2021, 433(5), 166795.
  • Lochhead PA, Tucker JA, Tatum NJ, Wang J, Oxley D, Kidger AM, Johnson VP, Cassidy MA, Gray NS, Noble MEM, Cook SJ. Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors. Nature Communications 2020, 11(1), 1383.
  • Tatum NJ, Duarte F, Kamerlin SCL, Pohl E. Relative binding energies predict crystallographic binding modes of ethionamide booster lead compounds. Journal of Physical Chemistry Letters 2019, 10(9), 2244-2249.
  • Wood DJ, Korolchuk S, Tatum NJ, Wang L-Z, Endicott JA, Noble MEM, Martin MP. Differences in the conformational energy landscape of CDK1 and CDK2 suggest a mechanism for achieving selective CDK inhibition. Cell Chemical Biology 2019, 26(1), 121-130.e5.
  • Haffez H, Chisholm DR, Tatum NJ, Valentine R, Redfern C, Pohl E, Whiting A, Przyborski S. Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids. Bioorganic & Medicinal Chemistry 2018, 26(8), 1560-1572.
  • Tatum NJ, Liebeschuetz JW, Cole JC, Frita R, Herledan A, Baulard AR, Willand N, Pohl, E. New leads for Tuberculosis booster drugs by structure-based drug discovery. Organic and Biomolecular Chemistry 2017, 15(48), 10245-10255.
  • Tatum NJ, Yufit DS, Cobb SL, Coxon CR. Synthesis, Ni(II) Schiff base complexation and structural analysis of fluorinated analogs of the ligand (S)-2-[N-(N′-benzylprolyl) amino] benzophenone (BPB). Journal of Fluorine Chemistry 2015, 173, 77-83.
  • Tatum NJ, Villemagne B, Willand N, Deprez B, Liebeschuetz JW, Baulard AR, Pohl E. Structural and docking studies of potent ethionamide boosters. Acta Crystallographica Section C: Crystal Structure Communications 2013, 69(11), 1243-1250.
  • Colgin N, Tatum NJ, Pohl E, Cobb SL, Sandford G. Synthesis and molecular structure of a perfluorinated pyridyl carbanion. Journal of Fluorine Chemistry 2012, 133, 33-37.

• Book Chapter

  • Martin MP, Endicott JA, Noble MEM, Tatum NJ. Crystallographic fragment screening in academic cancer drug discovery. In: Methods in Enzymology. San Diego: Academic Press Inc, 2023, pp.211-234.

• Reviews

  • Tatum NJ, Endicott JA. Chatterboxes: the structural and functional diversity of cyclins. Seminars in Cell and Developmental Biology 2020, 107, 4-20.
  • Lightfoot HL, Hagen T, Tatum NJ, Hall J. The diverse structural landscape of quadruplexes. FEBS Letters 2019, 593(16), 2083-2102.